On March 3, the U.S. Food and Drug Administration (FDA) updated a January recall for 912,119 total Medtronic MiniMed insulin pump products. It is now categorized as a Class II event, meaning the ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor ...